Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Flow Restriction Therapy to Prevent Muscle Atrophy Following Anterior Cruciate Ligament Reconstruction

NCT03794570 is registered in ClinicalTrials.gov with Steadman Philippon Research Institute as lead sponsor.

NCT NCT03794570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03794570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Flow Restriction Therapy to Prevent Muscle Atrophy Following Anterior Cruciate Ligament Reconstruction
Lead sponsor
Steadman Philippon Research Institute
Phase
Not applicable
Overall status
Withdrawn
Start date
December 18, 2018
Completion date
June 1, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acl injury, quadriceps muscle atrophy